Literature DB >> 34718464

Universal Community Nucleic Acid Testing for Coronavirus Disease 2019 (COVID-19) in Hong Kong Reveals Insights Into Transmission Dynamics: A Cross-Sectional and Modeling Study.

Bingyi Yang1, Tim K Tsang1, Huizhi Gao1, Eric H Y Lau1,2, Yun Lin1, Faith Ho1, Jingyi Xiao1, Jessica Y Wong1, Dillon C Adam1, Qiuyan Liao1, Peng Wu1,2, Benjamin J Cowling1,2, Gabriel M Leung1,2.   

Abstract

BACKGROUND: Testing of an entire community has been used as an approach to control coronavirus disease 2019 (COVID-19). In Hong Kong, a universal community testing program (UCTP) was implemented at the fadeout phase of a community epidemic in July to September 2020. We described the utility of the UCTP in finding unrecognized infections and analyzed data from the UCTP and other sources to characterize transmission dynamics.
METHODS: We described the characteristics of people participating in the UCTP and compared the clinical and epidemiological characteristics of COVID-19 cases detected by the UCTP versus those detected by clinical diagnosis and public health surveillance (CDPHS). We developed a Bayesian model to estimate the age-specific incidence of infection and the proportion of cases detected by CDPHS.
RESULTS: In total, 1.77 million people, 24% of the Hong Kong population, participated in the UCTP from 1 to 14 September 2020. The UCTP identified 32 new infections (1.8 per 100000 samples tested), consisting of 29% of all local cases reported during the two-week UCTP period. Compared with the CDPHS, the UCTP detected a higher proportion of sporadic cases (62% vs 27%, P<.01) and identified 6 (out of 18) additional clusters during that period. We estimated that 27% (95% credible interval: 22%, 34%) of all infections were detected by the CDPHS in the third wave.
CONCLUSIONS: We reported empirical evidence of the utility of population-wide COVID-19 testing in detecting unrecognized infections and clusters. Around three quarters of infections have not been identified through existing surveillance approaches including contact tracing.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; disease burden; mass testing; surveillance; transmission dynamics

Mesh:

Substances:

Year:  2022        PMID: 34718464     DOI: 10.1093/cid/ciab925

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   20.999


  3 in total

1.  Incorporating temporal distribution of population-level viral load enables real-time estimation of COVID-19 transmission.

Authors:  Yun Lin; Bingyi Yang; Sarah Cobey; Eric H Y Lau; Dillon C Adam; Jessica Y Wong; Helen S Bond; Justin K Cheung; Faith Ho; Huizhi Gao; Sheikh Taslim Ali; Nancy H L Leung; Tim K Tsang; Peng Wu; Gabriel M Leung; Benjamin J Cowling
Journal:  Nat Commun       Date:  2022-03-03       Impact factor: 14.919

2.  Preferences for Attributes of Initial COVID-19 Diagnosis in the United States and China During the Pandemic: Discrete Choice Experiment With Propensity Score Matching.

Authors:  Yimin Zhang; Taoran Liu; Zonglin He; Casper J P Zhang; Wai-Kit Ming; Sze Ngai Chan; Babatunde Akinwunmi; Jian Huang; Tak-Hap Wong
Journal:  JMIR Public Health Surveill       Date:  2022-08-16

3.  Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022.

Authors:  Yonatan M Mefsin; Dongxuan Chen; Helen S Bond; Yun Lin; Justin K Cheung; Jessica Y Wong; Sheikh Taslim Ali; Eric H Y Lau; Peng Wu; Gabriel M Leung; Benjamin J Cowling
Journal:  Emerg Infect Dis       Date:  2022-08-01       Impact factor: 16.126

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.